FLEURY S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.54 BRL | +3.78% |
|
+3.42% | -19.46% |
| May. 10 | Fleury Seeks Acquisitions | CI |
| May. 10 | Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024 |
ETFs positioned on Fleury S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 2 M€ | -14.14% | ||
| 0.24% | 14 M€ | -4.02% | ||
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 112 M€ | +5.01% | - | |
| 0.00% | 7 M€ | +6.05% | - | |
| 0.00% | 34 M€ | +4.32% | - |
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Calendar
2024-08-07
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
14.41
BRL
Average target price
19.33
BRL
Spread / Average Target
+34.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.46% | 1.49B | |
| -22.94% | 7.77B | |
| +77.51% | 4.51B | |
| +6.87% | 2.76B | |
| -2.10% | 2.67B | |
| -47.96% | 2.09B | |
| -16.47% | 1.72B | |
| +18.29% | 1.22B | |
| -44.77% | 1.12B | |
| +20.68% | 1.05B |
- Stock Market
- Equities
- FLRY3 Stock
- Funds and ETFs Fleury S.A.
